VENOUS THROMBOEMBOLIC DISEASE
Clinical trials for VENOUS THROMBOEMBOLIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLIC DISEASE trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood clot patients on heart meds: safer combo sought in major trial
Disease control Recruiting nowThis study looks for the best way to treat people who have a blood clot (like in the leg or lung) and also take daily aspirin or similar drugs for heart disease. Both conditions need blood thinners, but taking them together raises the risk of dangerous bleeding. The trial will co…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Pill vs. needle: can Lower-Dose blood thinners protect cancer patients from deadly clots?
Disease control Recruiting nowThis study looks at whether lower doses of two blood-thinning pills (apixaban and rivaroxaban) work as well as standard injections to prevent dangerous blood clots in people with blood cancers like lymphoma, leukemia, and multiple myeloma. About 100 participants will be randomly …
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Blood thinner breakthrough could slash clot risk in rare anemia
Prevention Recruiting nowThis study tests whether taking a blood thinner (apixaban) for 12 weeks can prevent dangerous blood clots in people with autoimmune hemolytic anemia (AIHA), a rare disease where the immune system destroys red blood cells. About 72 adults with newly diagnosed or relapsed AIHA will…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Prevention
Last updated May 22, 2026 14:01 UTC
-
Massive chinese trial aims to stop silent killer clots in hospitals
Knowledge-focused Recruiting nowThis study tests whether a hospital-wide quality improvement program can increase the use of blood clot prevention methods (like blood thinners or compression devices) in hospitalized patients. About 5,800 adults across multiple hospitals in China will take part. The goal is to s…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC